EMA beginnt "rolling review" für Omikron-Varianten-Impfstoffe von BioNTech
Aug. 09
Posted by
Dr. Steffen Rabe
in
Uncategorized
EU regulator begins review of Pfizer-BioNTech's variant-adapted COVID shot | Reuters
The European Medicines Agency (EMA) has started a rolling review of a variant-adapted COVID-19 vaccine from Pfizer and BioNTech , it said on Tuesday.
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-regulator-begins-review-pfizer-biontechs-variant-adapted-covid-shot-2022-08-09/
Tags:
EMA
PRINT